NATURECELL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,740 KRW | +1.46% |
|
+0.41% | +21.90% |
| 2023 | NatureCell Co.,Ltd. announced that it has received KRW 5 billion in funding | CI |
| 2023 | NatureCell to Raise 5 Billion Won via Stock Sale | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 1,114,763 | 955,217 | 512,616 |
| Enterprise Value (EV) 1 | 1,084,751 | 949,492 | 485,039 |
| P/E ratio | -34.3 x | -140 x | -43.5 x |
| Yield | - | - | - |
| Capitalization / Revenue | 54.8 x | 44.3 x | 26.5 x |
| EV / Revenue | 53.3 x | 44.1 x | 25.1 x |
| EV / EBITDA | -164 x | -159 x | -57.3 x |
| EV / FCF | - | -33,796,069 x | 78,936,905 x |
| FCF Yield | - | -0% | 0% |
| Price to Book | 18.3 x | 16.7 x | 8.35 x |
| Nbr of stocks (in thousands) | 62,627 | 62,637 | 64,157 |
| Reference price 2 | 17,800 | 15,250 | 7,990 |
| Announcement Date | 23/03/23 | 23/03/23 | 21/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 20,354 | 21,554 | 19,351 |
| EBITDA 1 | -6,617 | -5,953 | -8,469 |
| EBIT 1 | -8,465 | -7,285 | -10,220 |
| Operating Margin | -41.59% | -33.8% | -52.81% |
| Earnings before Tax (EBT) 1 | -30,014 | -8,905 | -11,571 |
| Net income 1 | -32,031 | -6,814 | -11,680 |
| Net margin | -157.37% | -31.61% | -60.36% |
| EPS 2 | -518.7 | -108.8 | -183.8 |
| Free Cash Flow | - | -28,095 | 6,145 |
| FCF margin | - | -130.34% | 31.75% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 23/03/23 | 23/03/23 | 21/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | - | - |
| Net Cash position 1 | 30,013 | 5,725 | 27,577 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -28,095 | 6,145 |
| ROE (net income / shareholders' equity) | - | -15.1% | -19.3% |
| ROA (Net income/ Total Assets) | - | -5.56% | -7.87% |
| Assets 1 | - | 122,461 | 148,505 |
| Book Value Per Share 2 | 972.0 | 913.0 | 957.0 |
| Cash Flow per Share 2 | 520.0 | 499.0 | 466.0 |
| Capex 1 | 384 | 3,793 | 6,124 |
| Capex / Sales | 1.88% | 17.6% | 31.65% |
| Announcement Date | 23/03/23 | 23/03/23 | 21/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +21.90% | 458M | |
| -0.07% | 89.46B | |
| +2.76% | 40.74B | |
| -9.06% | 33.03B | |
| +55.32% | 24.68B | |
| -16.61% | 15.12B | |
| -9.14% | 12.81B | |
| -12.11% | 11.79B | |
| -43.61% | 11.64B | |
| +7.79% | 8.9B |
- Stock Market
- Equities
- A007390 Stock
- Financials NatureCell Co.,Ltd.
